nodes	percent_of_prediction	percent_of_DWPC	metapath
Atomoxetine—HTR2C—metabolic syndrome X	0.725	1	CbGaD
Atomoxetine—Viral diarrhoea—Metformin—metabolic syndrome X	0.0109	0.0982	CcSEcCtD
Atomoxetine—SLC6A2—sympathetic nervous system—metabolic syndrome X	0.00998	0.134	CbGeAlD
Atomoxetine—HTR2A—arteriole—metabolic syndrome X	0.00942	0.126	CbGeAlD
Atomoxetine—Sinus headache—Metformin—metabolic syndrome X	0.00874	0.0787	CcSEcCtD
Atomoxetine—SLC6A2—autonomic nervous system—metabolic syndrome X	0.00671	0.0899	CbGeAlD
Atomoxetine—HTR2A—sympathetic nervous system—metabolic syndrome X	0.006	0.0804	CbGeAlD
Atomoxetine—Sinus congestion—Metformin—metabolic syndrome X	0.00573	0.0515	CcSEcCtD
Atomoxetine—Epigastric discomfort—Metformin—metabolic syndrome X	0.00542	0.0488	CcSEcCtD
Atomoxetine—Gastrointestinal symptom NOS—Metformin—metabolic syndrome X	0.00485	0.0436	CcSEcCtD
Atomoxetine—HTR1B—artery—metabolic syndrome X	0.00476	0.0637	CbGeAlD
Atomoxetine—HTR1D—artery—metabolic syndrome X	0.0046	0.0617	CbGeAlD
Atomoxetine—Upset stomach—Metformin—metabolic syndrome X	0.00435	0.0391	CcSEcCtD
Atomoxetine—HTR2A—autonomic nervous system—metabolic syndrome X	0.00403	0.0541	CbGeAlD
Atomoxetine—HTR1B—blood vessel—metabolic syndrome X	0.0037	0.0496	CbGeAlD
Atomoxetine—HTR1D—blood vessel—metabolic syndrome X	0.00359	0.0481	CbGeAlD
Atomoxetine—Rhinorrhoea—Metformin—metabolic syndrome X	0.00352	0.0317	CcSEcCtD
Atomoxetine—Rigors—Metformin—metabolic syndrome X	0.00349	0.0314	CcSEcCtD
Atomoxetine—NPY1R—adipose tissue—metabolic syndrome X	0.00344	0.046	CbGeAlD
Atomoxetine—NPY1R—liver—metabolic syndrome X	0.00241	0.0323	CbGeAlD
Atomoxetine—HTR2A—artery—metabolic syndrome X	0.00229	0.0306	CbGeAlD
Atomoxetine—Nasal congestion—Metformin—metabolic syndrome X	0.00227	0.0204	CcSEcCtD
Atomoxetine—Lethargy—Metformin—metabolic syndrome X	0.00211	0.019	CcSEcCtD
Atomoxetine—HTR2A—endothelium—metabolic syndrome X	0.00193	0.0259	CbGeAlD
Atomoxetine—Abdominal pain upper—Metformin—metabolic syndrome X	0.00189	0.017	CcSEcCtD
Atomoxetine—Breast disorder—Metformin—metabolic syndrome X	0.00187	0.0168	CcSEcCtD
Atomoxetine—Nasopharyngitis—Metformin—metabolic syndrome X	0.00185	0.0166	CcSEcCtD
Atomoxetine—Influenza—Metformin—metabolic syndrome X	0.00179	0.0161	CcSEcCtD
Atomoxetine—HTR2A—blood vessel—metabolic syndrome X	0.00178	0.0239	CbGeAlD
Atomoxetine—Sweating increased—Metformin—metabolic syndrome X	0.00174	0.0157	CcSEcCtD
Atomoxetine—Abdominal discomfort—Metformin—metabolic syndrome X	0.00171	0.0154	CcSEcCtD
Atomoxetine—Upper respiratory tract infection—Metformin—metabolic syndrome X	0.00166	0.015	CcSEcCtD
Atomoxetine—HTR1B—cardiovascular system—metabolic syndrome X	0.00165	0.0221	CbGeAlD
Atomoxetine—HTR1D—cardiovascular system—metabolic syndrome X	0.0016	0.0214	CbGeAlD
Atomoxetine—Infestation—Metformin—metabolic syndrome X	0.00159	0.0143	CcSEcCtD
Atomoxetine—Infestation NOS—Metformin—metabolic syndrome X	0.00159	0.0143	CcSEcCtD
Atomoxetine—HTR1D—kidney—metabolic syndrome X	0.00157	0.021	CbGeAlD
Atomoxetine—Hypoaesthesia—Metformin—metabolic syndrome X	0.00142	0.0128	CcSEcCtD
Atomoxetine—Flushing—Metformin—metabolic syndrome X	0.00133	0.012	CcSEcCtD
Atomoxetine—Cardiac disorder—Metformin—metabolic syndrome X	0.00133	0.012	CcSEcCtD
Atomoxetine—Angiopathy—Metformin—metabolic syndrome X	0.0013	0.0117	CcSEcCtD
Atomoxetine—Mediastinal disorder—Metformin—metabolic syndrome X	0.00129	0.0116	CcSEcCtD
Atomoxetine—Chills—Metformin—metabolic syndrome X	0.00128	0.0116	CcSEcCtD
Atomoxetine—Malnutrition—Metformin—metabolic syndrome X	0.00125	0.0112	CcSEcCtD
Atomoxetine—Flatulence—Metformin—metabolic syndrome X	0.00123	0.011	CcSEcCtD
Atomoxetine—Dysgeusia—Metformin—metabolic syndrome X	0.00122	0.011	CcSEcCtD
Atomoxetine—Muscle spasms—Metformin—metabolic syndrome X	0.0012	0.0108	CcSEcCtD
Atomoxetine—Vision blurred—Metformin—metabolic syndrome X	0.00117	0.0106	CcSEcCtD
Atomoxetine—Tremor—Metformin—metabolic syndrome X	0.00117	0.0105	CcSEcCtD
Atomoxetine—Syncope—Metformin—metabolic syndrome X	0.00112	0.0101	CcSEcCtD
Atomoxetine—Palpitations—Metformin—metabolic syndrome X	0.0011	0.00991	CcSEcCtD
Atomoxetine—Loss of consciousness—Metformin—metabolic syndrome X	0.00109	0.00985	CcSEcCtD
Atomoxetine—Myalgia—Metformin—metabolic syndrome X	0.00106	0.00954	CcSEcCtD
Atomoxetine—Chest pain—Metformin—metabolic syndrome X	0.00106	0.00954	CcSEcCtD
Atomoxetine—Unspecified disorder of skin and subcutaneous tissue—Metformin—metabolic syndrome X	0.00105	0.00948	CcSEcCtD
Atomoxetine—Infection—Metformin—metabolic syndrome X	0.00101	0.00909	CcSEcCtD
Atomoxetine—Shock—Metformin—metabolic syndrome X	0.001	0.009	CcSEcCtD
Atomoxetine—Nervous system disorder—Metformin—metabolic syndrome X	0.000997	0.00897	CcSEcCtD
Atomoxetine—Skin disorder—Metformin—metabolic syndrome X	0.000987	0.00889	CcSEcCtD
Atomoxetine—Hyperhidrosis—Metformin—metabolic syndrome X	0.000983	0.00884	CcSEcCtD
Atomoxetine—Anorexia—Metformin—metabolic syndrome X	0.000969	0.00872	CcSEcCtD
Atomoxetine—Reboxetine—HTR2C—metabolic syndrome X	0.000931	0.16	CrCbGaD
Atomoxetine—Musculoskeletal discomfort—Metformin—metabolic syndrome X	0.000926	0.00834	CcSEcCtD
Atomoxetine—Paraesthesia—Metformin—metabolic syndrome X	0.000913	0.00822	CcSEcCtD
Atomoxetine—Somnolence—Metformin—metabolic syndrome X	0.000904	0.00813	CcSEcCtD
Atomoxetine—Dyspepsia—Metformin—metabolic syndrome X	0.000895	0.00805	CcSEcCtD
Atomoxetine—Decreased appetite—Metformin—metabolic syndrome X	0.000884	0.00795	CcSEcCtD
Atomoxetine—Gastrointestinal disorder—Metformin—metabolic syndrome X	0.000878	0.0079	CcSEcCtD
Atomoxetine—Fatigue—Metformin—metabolic syndrome X	0.000876	0.00789	CcSEcCtD
Atomoxetine—Constipation—Metformin—metabolic syndrome X	0.000869	0.00782	CcSEcCtD
Atomoxetine—Feeling abnormal—Metformin—metabolic syndrome X	0.000838	0.00754	CcSEcCtD
Atomoxetine—Gastrointestinal pain—Metformin—metabolic syndrome X	0.000831	0.00748	CcSEcCtD
Atomoxetine—Urticaria—Metformin—metabolic syndrome X	0.000808	0.00727	CcSEcCtD
Atomoxetine—Abdominal pain—Metformin—metabolic syndrome X	0.000804	0.00723	CcSEcCtD
Atomoxetine—HTR2A—cardiovascular system—metabolic syndrome X	0.000795	0.0107	CbGeAlD
Atomoxetine—HTR2A—kidney—metabolic syndrome X	0.000778	0.0104	CbGeAlD
Atomoxetine—CYP2C19—liver—metabolic syndrome X	0.00077	0.0103	CbGeAlD
Atomoxetine—Asthenia—Metformin—metabolic syndrome X	0.000729	0.00656	CcSEcCtD
Atomoxetine—CYP3A4—kidney—metabolic syndrome X	0.00072	0.00965	CbGeAlD
Atomoxetine—Pruritus—Metformin—metabolic syndrome X	0.000719	0.00647	CcSEcCtD
Atomoxetine—Duloxetine—HTR2C—metabolic syndrome X	0.000716	0.123	CrCbGaD
Atomoxetine—CYP2D6—kidney—metabolic syndrome X	0.000708	0.00949	CbGeAlD
Atomoxetine—Diarrhoea—Metformin—metabolic syndrome X	0.000695	0.00626	CcSEcCtD
Atomoxetine—Dizziness—Metformin—metabolic syndrome X	0.000672	0.00605	CcSEcCtD
Atomoxetine—Vomiting—Metformin—metabolic syndrome X	0.000646	0.00582	CcSEcCtD
Atomoxetine—Rash—Metformin—metabolic syndrome X	0.000641	0.00577	CcSEcCtD
Atomoxetine—Dermatitis—Metformin—metabolic syndrome X	0.00064	0.00576	CcSEcCtD
Atomoxetine—Headache—Metformin—metabolic syndrome X	0.000637	0.00573	CcSEcCtD
Atomoxetine—Nausea—Metformin—metabolic syndrome X	0.000604	0.00543	CcSEcCtD
Atomoxetine—Fluoxetine—HTR2C—metabolic syndrome X	0.000584	0.1	CrCbGaD
Atomoxetine—Maprotiline—HTR2C—metabolic syndrome X	0.000545	0.0939	CrCbGaD
Atomoxetine—Pseudoephedrine—TNF—metabolic syndrome X	0.000522	0.0899	CrCbGaD
Atomoxetine—HTR2A—liver—metabolic syndrome X	0.000492	0.00659	CbGeAlD
Atomoxetine—CYP3A4—liver—metabolic syndrome X	0.000455	0.0061	CbGeAlD
Atomoxetine—CYP2D6—liver—metabolic syndrome X	0.000448	0.006	CbGeAlD
Atomoxetine—Fenoprofen—PTGS2—metabolic syndrome X	0.00034	0.0586	CrCbGaD
Atomoxetine—Nortriptyline—HTR2C—metabolic syndrome X	0.000328	0.0564	CrCbGaD
Atomoxetine—Fenoprofen—ALB—metabolic syndrome X	0.000303	0.0522	CrCbGaD
Atomoxetine—Desipramine—HTR2C—metabolic syndrome X	0.00027	0.0464	CrCbGaD
Atomoxetine—Phenprocoumon—ALB—metabolic syndrome X	0.000261	0.045	CrCbGaD
Atomoxetine—Fluoxetine—ALB—metabolic syndrome X	0.000254	0.0438	CrCbGaD
Atomoxetine—Warfarin—ALB—metabolic syndrome X	0.000232	0.0399	CrCbGaD
Atomoxetine—Ketoprofen—PTGS2—metabolic syndrome X	0.000201	0.0346	CrCbGaD
Atomoxetine—Ketoprofen—ALB—metabolic syndrome X	0.000179	0.0308	CrCbGaD
Atomoxetine—Nortriptyline—ALB—metabolic syndrome X	0.000143	0.0246	CrCbGaD
Atomoxetine—HTR1D—Signaling by GPCR—CCL2—metabolic syndrome X	2.85e-05	0.000344	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—RBP4—metabolic syndrome X	2.83e-05	0.000341	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—TRIB3—metabolic syndrome X	2.83e-05	0.000341	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR downstream signaling—AGT—metabolic syndrome X	2.83e-05	0.000341	CbGpPWpGaD
Atomoxetine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—metabolic syndrome X	2.82e-05	0.00034	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—FABP4—metabolic syndrome X	2.79e-05	0.000337	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism of lipids and lipoproteins—APOB—metabolic syndrome X	2.79e-05	0.000337	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling by GPCR—CCL2—metabolic syndrome X	2.79e-05	0.000337	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4A—metabolic syndrome X	2.72e-05	0.000327	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling Pathways—TGFB1—metabolic syndrome X	2.71e-05	0.000327	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—CCL5—metabolic syndrome X	2.67e-05	0.000322	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism of lipids and lipoproteins—LPL—metabolic syndrome X	2.67e-05	0.000321	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—PLA2G4A—metabolic syndrome X	2.66e-05	0.00032	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—HSD11B1—metabolic syndrome X	2.65e-05	0.000319	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—IGF2—metabolic syndrome X	2.6e-05	0.000313	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—IGF2—metabolic syndrome X	2.58e-05	0.000311	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—AGT—metabolic syndrome X	2.57e-05	0.00031	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—G6PD—metabolic syndrome X	2.57e-05	0.00031	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—FMO3—metabolic syndrome X	2.56e-05	0.000309	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism of lipids and lipoproteins—CD36—metabolic syndrome X	2.53e-05	0.000305	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—CYBA—metabolic syndrome X	2.52e-05	0.000304	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—IGF2—metabolic syndrome X	2.52e-05	0.000304	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—APOB—metabolic syndrome X	2.52e-05	0.000304	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—APOC3—metabolic syndrome X	2.51e-05	0.000302	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—HDAC3—metabolic syndrome X	2.51e-05	0.000302	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—APOB—metabolic syndrome X	2.5e-05	0.000302	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—GHRL—metabolic syndrome X	2.47e-05	0.000298	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—CCL5—metabolic syndrome X	2.46e-05	0.000297	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR downstream signaling—AGT—metabolic syndrome X	2.46e-05	0.000296	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—PLA2G4A—metabolic syndrome X	2.45e-05	0.000296	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—APOB—metabolic syndrome X	2.45e-05	0.000296	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—GCKR—metabolic syndrome X	2.45e-05	0.000295	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—LPA—metabolic syndrome X	2.45e-05	0.000295	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—CCL5—metabolic syndrome X	2.44e-05	0.000295	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—PLA2G4A—metabolic syndrome X	2.43e-05	0.000294	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—LPL—metabolic syndrome X	2.41e-05	0.00029	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—CCL5—metabolic syndrome X	2.39e-05	0.000289	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—LPL—metabolic syndrome X	2.39e-05	0.000288	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—PLA2G4A—metabolic syndrome X	2.38e-05	0.000288	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—PLA2G6—metabolic syndrome X	2.37e-05	0.000286	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—G6PD—metabolic syndrome X	2.36e-05	0.000285	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—metabolic syndrome X	2.35e-05	0.000284	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—APOA5—metabolic syndrome X	2.35e-05	0.000283	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—LPL—metabolic syndrome X	2.34e-05	0.000282	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—CNR1—metabolic syndrome X	2.34e-05	0.000282	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—HDAC3—metabolic syndrome X	2.3e-05	0.000278	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—MLXIPL—metabolic syndrome X	2.29e-05	0.000276	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—EPHX2—metabolic syndrome X	2.29e-05	0.000276	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism of lipids and lipoproteins—AGT—metabolic syndrome X	2.28e-05	0.000275	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—HTR2C—metabolic syndrome X	2.26e-05	0.000273	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—GCKR—metabolic syndrome X	2.25e-05	0.000272	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—LPA—metabolic syndrome X	2.25e-05	0.000272	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—metabolic syndrome X	2.23e-05	0.000269	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—AGT—metabolic syndrome X	2.23e-05	0.000269	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—metabolic syndrome X	2.21e-05	0.000266	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—CYBA—metabolic syndrome X	2.19e-05	0.000264	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—TRIB3—metabolic syndrome X	2.18e-05	0.000263	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—PLA2G6—metabolic syndrome X	2.18e-05	0.000263	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—APOA5—metabolic syndrome X	2.16e-05	0.00026	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—G6PC2—metabolic syndrome X	2.15e-05	0.000259	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—GHRL—metabolic syndrome X	2.15e-05	0.000259	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—CCL2—metabolic syndrome X	2.12e-05	0.000255	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—AGT—metabolic syndrome X	2.06e-05	0.000248	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—AGT—metabolic syndrome X	2.04e-05	0.000247	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling Pathways—IL6—metabolic syndrome X	2.04e-05	0.000246	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—CNR1—metabolic syndrome X	2.03e-05	0.000245	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—LEP—metabolic syndrome X	2.02e-05	0.000243	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—APOE—metabolic syndrome X	2.02e-05	0.000243	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—TRIB3—metabolic syndrome X	2.01e-05	0.000242	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—APOE—metabolic syndrome X	2e-05	0.000242	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—LEP—metabolic syndrome X	2e-05	0.000242	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—AGT—metabolic syndrome X	2e-05	0.000241	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—APOA1—metabolic syndrome X	2e-05	0.000241	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—APOA1—metabolic syndrome X	1.98e-05	0.000239	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—LEP—metabolic syndrome X	1.96e-05	0.000237	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—APOE—metabolic syndrome X	1.96e-05	0.000237	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—NAMPT—metabolic syndrome X	1.96e-05	0.000236	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—metabolic syndrome X	1.95e-05	0.000235	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—LIPC—metabolic syndrome X	1.95e-05	0.000235	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—GCK—metabolic syndrome X	1.95e-05	0.000235	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—APOA1—metabolic syndrome X	1.94e-05	0.000234	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—APOC3—metabolic syndrome X	1.93e-05	0.000233	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—IGF2—metabolic syndrome X	1.91e-05	0.000231	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling Pathways—AKT1—metabolic syndrome X	1.88e-05	0.000227	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—CETP—metabolic syndrome X	1.88e-05	0.000226	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—APOB—metabolic syndrome X	1.86e-05	0.000224	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—CCL2—metabolic syndrome X	1.84e-05	0.000222	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—FABP4—metabolic syndrome X	1.83e-05	0.00022	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—CCL5—metabolic syndrome X	1.81e-05	0.000219	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—PLA2G4A—metabolic syndrome X	1.81e-05	0.000218	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—IRS1—metabolic syndrome X	1.8e-05	0.000217	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—NAMPT—metabolic syndrome X	1.8e-05	0.000217	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—SCARB1—metabolic syndrome X	1.8e-05	0.000217	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—LIPC—metabolic syndrome X	1.79e-05	0.000216	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—GCK—metabolic syndrome X	1.79e-05	0.000216	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—IRS1—metabolic syndrome X	1.79e-05	0.000216	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—APOC3—metabolic syndrome X	1.78e-05	0.000214	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—LPL—metabolic syndrome X	1.77e-05	0.000214	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—metabolic syndrome X	1.75e-05	0.000211	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—IRS1—metabolic syndrome X	1.75e-05	0.000211	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—SREBF1—metabolic syndrome X	1.74e-05	0.00021	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—HSD11B1—metabolic syndrome X	1.73e-05	0.000209	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—CETP—metabolic syndrome X	1.73e-05	0.000208	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—INS—metabolic syndrome X	1.72e-05	0.000208	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—INS—metabolic syndrome X	1.71e-05	0.000206	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—GOT2—metabolic syndrome X	1.7e-05	0.000205	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—HMGCR—metabolic syndrome X	1.7e-05	0.000205	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—CCL2—metabolic syndrome X	1.7e-05	0.000205	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—CCL2—metabolic syndrome X	1.68e-05	0.000203	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—INS—metabolic syndrome X	1.68e-05	0.000202	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—IGF1—metabolic syndrome X	1.67e-05	0.000201	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—IGF2—metabolic syndrome X	1.66e-05	0.0002	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—IGF1—metabolic syndrome X	1.66e-05	0.0002	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—SCARB1—metabolic syndrome X	1.65e-05	0.000199	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—CCL2—metabolic syndrome X	1.65e-05	0.000199	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—IGF1—metabolic syndrome X	1.62e-05	0.000195	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—APOB—metabolic syndrome X	1.61e-05	0.000195	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—SREBF1—metabolic syndrome X	1.6e-05	0.000194	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—SERPINE1—metabolic syndrome X	1.58e-05	0.000191	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—CCL5—metabolic syndrome X	1.57e-05	0.00019	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—SERPINE1—metabolic syndrome X	1.57e-05	0.00019	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—PLA2G4A—metabolic syndrome X	1.57e-05	0.000189	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—GOT2—metabolic syndrome X	1.56e-05	0.000188	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—HMGCR—metabolic syndrome X	1.56e-05	0.000188	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—G6PD—metabolic syndrome X	1.54e-05	0.000186	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—LPL—metabolic syndrome X	1.54e-05	0.000186	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—SERPINE1—metabolic syndrome X	1.54e-05	0.000186	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	1.53e-05	0.000185	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—AGT—metabolic syndrome X	1.52e-05	0.000183	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—ABCA1—metabolic syndrome X	1.51e-05	0.000182	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—SLC2A4—metabolic syndrome X	1.51e-05	0.000182	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—NOS3—metabolic syndrome X	1.51e-05	0.000182	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—HDAC3—metabolic syndrome X	1.51e-05	0.000182	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—NOS3—metabolic syndrome X	1.5e-05	0.000181	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—LEP—metabolic syndrome X	1.49e-05	0.000179	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—APOE—metabolic syndrome X	1.49e-05	0.000179	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—GCKR—metabolic syndrome X	1.47e-05	0.000178	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—LPA—metabolic syndrome X	1.47e-05	0.000178	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—NOS3—metabolic syndrome X	1.47e-05	0.000177	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—APOA1—metabolic syndrome X	1.47e-05	0.000177	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—GGT1—metabolic syndrome X	1.47e-05	0.000177	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—GOT1—metabolic syndrome X	1.47e-05	0.000177	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—PLA2G6—metabolic syndrome X	1.43e-05	0.000172	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—APOA5—metabolic syndrome X	1.41e-05	0.00017	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—ABCA1—metabolic syndrome X	1.39e-05	0.000168	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—SLC2A4—metabolic syndrome X	1.39e-05	0.000168	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—GOT1—metabolic syndrome X	1.35e-05	0.000163	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—GGT1—metabolic syndrome X	1.35e-05	0.000163	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—IRS1—metabolic syndrome X	1.33e-05	0.00016	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—AGT—metabolic syndrome X	1.32e-05	0.000159	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—TRIB3—metabolic syndrome X	1.31e-05	0.000158	CbGpPWpGaD
Atomoxetine—HTR6—GPCR downstream signaling—AKT1—metabolic syndrome X	1.3e-05	0.000156	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—APOE—metabolic syndrome X	1.29e-05	0.000156	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—LEP—metabolic syndrome X	1.29e-05	0.000156	CbGpPWpGaD
Atomoxetine—HTR1D—GPCR downstream signaling—AKT1—metabolic syndrome X	1.29e-05	0.000155	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—APOA1—metabolic syndrome X	1.28e-05	0.000154	CbGpPWpGaD
Atomoxetine—HTR6—Signaling by GPCR—IL6—metabolic syndrome X	1.28e-05	0.000154	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—INS—metabolic syndrome X	1.27e-05	0.000153	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling by GPCR—IL6—metabolic syndrome X	1.27e-05	0.000153	CbGpPWpGaD
Atomoxetine—HTR1B—GPCR downstream signaling—AKT1—metabolic syndrome X	1.26e-05	0.000152	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—CCL2—metabolic syndrome X	1.25e-05	0.000151	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—APOB—metabolic syndrome X	1.24e-05	0.00015	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling by GPCR—IL6—metabolic syndrome X	1.24e-05	0.000149	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—IGF1—metabolic syndrome X	1.23e-05	0.000148	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—PLA2G4A—metabolic syndrome X	1.21e-05	0.000146	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—LPL—metabolic syndrome X	1.19e-05	0.000143	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—NAMPT—metabolic syndrome X	1.18e-05	0.000142	CbGpPWpGaD
Atomoxetine—HTR6—Signaling by GPCR—AKT1—metabolic syndrome X	1.18e-05	0.000142	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—LIPC—metabolic syndrome X	1.17e-05	0.000141	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—GCK—metabolic syndrome X	1.17e-05	0.000141	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling by GPCR—AKT1—metabolic syndrome X	1.17e-05	0.000141	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—SERPINE1—metabolic syndrome X	1.17e-05	0.000141	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—APOC3—metabolic syndrome X	1.16e-05	0.00014	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—IRS1—metabolic syndrome X	1.15e-05	0.000139	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling by GPCR—AKT1—metabolic syndrome X	1.14e-05	0.000138	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—APOB—metabolic syndrome X	1.14e-05	0.000138	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—CETP—metabolic syndrome X	1.13e-05	0.000136	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—CD36—metabolic syndrome X	1.13e-05	0.000136	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—NOS3—metabolic syndrome X	1.11e-05	0.000134	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—PLA2G4A—metabolic syndrome X	1.11e-05	0.000134	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—INS—metabolic syndrome X	1.1e-05	0.000133	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—LPL—metabolic syndrome X	1.09e-05	0.000132	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—CCL2—metabolic syndrome X	1.08e-05	0.000131	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—SCARB1—metabolic syndrome X	1.08e-05	0.00013	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—IGF1—metabolic syndrome X	1.07e-05	0.000129	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—SREBF1—metabolic syndrome X	1.05e-05	0.000127	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—PPARA—metabolic syndrome X	1.05e-05	0.000126	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—CD36—metabolic syndrome X	1.04e-05	0.000125	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—GOT2—metabolic syndrome X	1.02e-05	0.000123	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—HMGCR—metabolic syndrome X	1.02e-05	0.000123	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—AGT—metabolic syndrome X	1.02e-05	0.000122	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—SERPINE1—metabolic syndrome X	1.01e-05	0.000122	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—TGFB1—metabolic syndrome X	1e-05	0.000121	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—APOE—metabolic syndrome X	9.95e-06	0.00012	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—TGFB1—metabolic syndrome X	9.92e-06	0.00012	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—APOA1—metabolic syndrome X	9.84e-06	0.000119	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—TGFB1—metabolic syndrome X	9.72e-06	0.000117	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—NOS3—metabolic syndrome X	9.67e-06	0.000117	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—PPARA—metabolic syndrome X	9.64e-06	0.000116	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR downstream signaling—AKT1—metabolic syndrome X	9.54e-06	0.000115	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—IL6—metabolic syndrome X	9.39e-06	0.000113	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—AGT—metabolic syndrome X	9.34e-06	0.000113	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—APOE—metabolic syndrome X	9.15e-06	0.00011	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—ABCA1—metabolic syndrome X	9.1e-06	0.00011	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—SLC2A4—metabolic syndrome X	9.1e-06	0.00011	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—APOA1—metabolic syndrome X	9.05e-06	0.000109	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—GGT1—metabolic syndrome X	8.81e-06	0.000106	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—GOT1—metabolic syndrome X	8.81e-06	0.000106	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—PPARG—metabolic syndrome X	8.67e-06	0.000105	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—AKT1—metabolic syndrome X	8.67e-06	0.000105	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—INS—metabolic syndrome X	8.5e-06	0.000103	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR downstream signaling—AKT1—metabolic syndrome X	8.29e-06	9.99e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—IL6—metabolic syndrome X	8.16e-06	9.84e-05	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—PPARG—metabolic syndrome X	7.97e-06	9.61e-05	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—INS—metabolic syndrome X	7.82e-06	9.43e-05	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—ALB—metabolic syndrome X	7.79e-06	9.4e-05	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—IL6—metabolic syndrome X	7.53e-06	9.09e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—AKT1—metabolic syndrome X	7.53e-06	9.08e-05	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—IL6—metabolic syndrome X	7.48e-06	9.02e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—APOB—metabolic syndrome X	7.48e-06	9.02e-05	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—NOS3—metabolic syndrome X	7.45e-06	8.99e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—TGFB1—metabolic syndrome X	7.36e-06	8.88e-05	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—IL6—metabolic syndrome X	7.32e-06	8.83e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—PLA2G4A—metabolic syndrome X	7.27e-06	8.77e-05	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—ALB—metabolic syndrome X	7.17e-06	8.64e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—LPL—metabolic syndrome X	7.14e-06	8.61e-05	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—AKT1—metabolic syndrome X	6.95e-06	8.38e-05	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—AKT1—metabolic syndrome X	6.9e-06	8.32e-05	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—NOS3—metabolic syndrome X	6.86e-06	8.27e-05	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—PTGS2—metabolic syndrome X	6.82e-06	8.22e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—CD36—metabolic syndrome X	6.78e-06	8.18e-05	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—AKT1—metabolic syndrome X	6.75e-06	8.15e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—TGFB1—metabolic syndrome X	6.39e-06	7.71e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—PPARA—metabolic syndrome X	6.31e-06	7.6e-05	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—PTGS2—metabolic syndrome X	6.27e-06	7.56e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—AGT—metabolic syndrome X	6.11e-06	7.36e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—APOE—metabolic syndrome X	5.98e-06	7.22e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—APOA1—metabolic syndrome X	5.91e-06	7.13e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—IL6—metabolic syndrome X	5.55e-06	6.69e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—PPARG—metabolic syndrome X	5.21e-06	6.29e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—AKT1—metabolic syndrome X	5.12e-06	6.17e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—INS—metabolic syndrome X	5.11e-06	6.16e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—IL6—metabolic syndrome X	4.82e-06	5.81e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—ALB—metabolic syndrome X	4.69e-06	5.65e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—NOS3—metabolic syndrome X	4.48e-06	5.41e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—AKT1—metabolic syndrome X	4.45e-06	5.36e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—PTGS2—metabolic syndrome X	4.1e-06	4.94e-05	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—AKT1—metabolic syndrome X	3.43e-06	4.13e-05	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—AKT1—metabolic syndrome X	3.15e-06	3.8e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—AKT1—metabolic syndrome X	2.06e-06	2.49e-05	CbGpPWpGaD
